Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

(2019) Klaus Seppi et al.   MOVEMENT DISORDERS

New perspectives on study designs for evaluating neuroprotection in Parkinson's disease

(2017) Laetitia Thibault et al.   MOVEMENT DISORDERS

Parkinson disease

(2017) Werner Poewe et al.   Nature Reviews Disease Primers

Endocannabinoid system: Role in depression, reward and pain control (Review)

(2016) Wen-Juan Huang et al.   Molecular Medicine Reports

Non-motor symptoms in Parkinson's disease

(2016) Ronald F. Pfeiffer   PARKINSONISM & RELATED DISORDERS

Endocannabinoid Signaling Regulates Sleep Stability

(2016) Matthew J. Pava et al.   PLoS One

Drugs of abuse and Parkinson's disease

(2016) Leah R. Mursaleen et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity

(2015) Marie Fitzgibbon et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Parkinson's disease

(2015) Lorraine V Kalia et al.   LANCET

New clinical trials for nonmotor manifestations of Parkinson's disease

(2015) Anette Schrag et al.   MOVEMENT DISORDERS

The therapeutic potential of cannabinoids for movement disorders

(2015) Benzi Kluger et al.   MOVEMENT DISORDERS

Placebo effect of medication cost in Parkinson disease: A randomized double-blind study

(2015) A. J. Espay et al.   NEUROLOGY

Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial

(2015) Dana Turcotte et al.   PAIN MEDICINE

Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease

(2014) Itay Lotan et al.   CLINICAL NEUROPHARMACOLOGY

Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series

(2014) M. H. N. Chagas et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease (QUIP) and the QUIP-rating scale in a German speaking sample

(2014) Catharina Claudia Probst et al.   JOURNAL OF NEUROLOGY

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial

(2014) Marcos Hortes N Chagas et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS

(2014) Werner Poewe et al.   MOVEMENT DISORDERS

Characterization of the thalamic–subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients

(2013) Elisa Frisaldi et al.   CORTEX

Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse

(2013) Margaret Haney et al.   NEUROPSYCHOPHARMACOLOGY

Contribution of genetic variants to pain susceptibility in Parkinson disease

(2012) L. Greenbaum et al.   EUROPEAN JOURNAL OF PAIN

Endocannabinoid Signaling and Synaptic Function

(2012) Pablo E. Castillo et al.   NEURON

An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

(2012) Cory Toth et al.   PAIN

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials

(2011) Mary E. Lynch et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

(2011) Klaus Seppi et al.   MOVEMENT DISORDERS

The abuse potential of the synthetic cannabinoid nabilone

(2010) Mark A. Ware et al.   ADDICTION

Cannabidiol for the treatment of psychosis in Parkinson’s disease

(2008) AW Zuardi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS

The role of the CB1 receptor in the regulation of sleep

(2008) Eric Murillo-Rodríguez   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Nabilone for the Treatment of Pain in Fibromyalgia

(2007) Ryan Quinlan Skrabek et al.   JOURNAL OF PAIN